“DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 11, no. 1, Feb. 2019, p. e2019016, https://doi.org/10.4084/mjhid.2019.016.